Pyxis Oncology, Inc. (PYXS)

NASDAQ: PYXS · IEX Real-Time Price · USD
-0.04 (-2.58%)
At close: Nov 28, 2023, 4:00 PM
-0.03 (-1.99%)
After-hours: Nov 28, 2023, 5:43 PM EST

Total Valuation

Pyxis Oncology has a market cap or net worth of $66.93 million. The enterprise value is -$45.89 million.

Market Cap 66.93M
Enterprise Value -45.89M

Important Dates

The last earnings date was Tuesday, November 7, 2023, after market close.

Earnings Date Nov 7, 2023
Ex-Dividend Date n/a

Share Statistics

Pyxis Oncology has 44.32 million shares outstanding. The number of shares has increased by 26.94% in one year.

Shares Outstanding 44.32M
Shares Change (YoY) +26.94%
Shares Change (QoQ) +7.67%
Owned by Insiders (%) 30.93%
Owned by Institutions (%) 26.24%
Float 29.70M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.49
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.16.

Current Ratio 4.91
Quick Ratio n/a
Debt / Equity 0.16
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -63.30% and return on invested capital (ROIC) is -64.18%.

Return on Equity (ROE) -63.30%
Return on Assets (ROA) -49.90%
Return on Capital (ROIC) -64.18%
Revenue Per Employee n/a
Profits Per Employee -$1.41M
Employee Count 67
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +3.10% in the last 52 weeks. The beta is 1.12, so Pyxis Oncology's price volatility has been higher than the market average.

Beta (1Y) 1.12
52-Week Price Change +3.10%
50-Day Moving Average 1.72
200-Day Moving Average 2.47
Relative Strength Index (RSI) 41.67
Average Volume (30 Days) 124,473

Short Selling Information

The latest short interest is 801,069, so 1.81% of the outstanding shares have been sold short.

Short Interest 801,069
Short Previous Month 792,474
Short % of Shares Out 1.81%
Short % of Float 2.70%
Short Ratio (days to cover) 9.29

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -102.40M
Pretax Income -94.29M
Net Income -94.29M
EBITDA -92.12M
EBIT -94.29M
Earnings Per Share (EPS) -$2.55
Full Income Statement

Balance Sheet

The company has $134.44 million in cash and $21.62 million in debt, giving a net cash position of $112.82 million or $2.55 per share.

Cash & Cash Equivalents 134.44M
Total Debt 21.62M
Net Cash 112.82M
Net Cash Per Share $2.55
Equity / Book Value 137.95M
Book Value Per Share 3.11
Working Capital 110.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$72.84 million and capital expenditures -$8.58 million, giving a free cash flow of -$81.43 million.

Operating Cash Flow -72.84M
Capital Expenditures -8.58M
Free Cash Flow -81.43M
FCF Per Share -$1.97
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Pyxis Oncology does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -140.89%
FCF Yield -121.66%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -26.94%
Shareholder Yield -26.94%

Analyst Forecast

The average price target for Pyxis Oncology is $12.00, which is 694.70% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.00
Price Target Difference 694.70%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -5.83%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 1